SCHEMBL4059355

SCHEMBL4059355

COc1cc2ccccc2cc1C=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.61
KDM4E B2RXH2 2/20 0.61
TSHR P16473 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
ERN1 O75460 5/20 0.53
HPGD P15428 2/20 0.50
NQO1 P15559 1/20 0.50
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
TLR2 O60603 1/20 0.47
TLR1 Q15399 1/20 0.47
TLR6 Q9Y2C9 1/20 0.47
FGFR1 P11362 1/20 0.47
PRKDC P78527 1/20 0.46
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11299778 0.96 ALDH1A1 (0.57) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL1487621 0.87 ALDH1A1 (0.71) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL4935526 0.82 ALDH1A1 (0.53) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL11230561 0.82 ALDH1A1 (0.55) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL24953221 0.81 SLC2A1 (0.48) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL25622473 0.80 ERN1 (0.47) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL14733961 0.80 ALDH1A1 (0.54) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL2046583 0.80 ALDH1A1 (0.52) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL14931681 0.80 ALDH1A1 (0.52) ALDH1A1KDM4ETSHRTDP1ERN1
SCHEMBL3136850 0.80 ALDH1A1 (0.90) ALDH1A1KDM4ETSHRTDP1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12251679-B2 Multivariate metal-organic frameworks for fine-tuning light emission UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2025-03-18 US disclosed
US-11839613-B2 Pyrimidine derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2023-12-12 US disclosed
US-20230381740-A1 MULTIVARIATE METAL-ORGANIC FRAMEWORKS FOR FINE-TUNING LIGHT EMISSION UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. 2023-11-30 US disclosed
US-20230381740-A1 MULTIVARIATE METAL-ORGANIC FRAMEWORKS FOR FINE-TUNING LIGHT EMISSION UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. 2023-11-30 US disclosed
US-20230381740-A1 MULTIVARIATE METAL-ORGANIC FRAMEWORKS FOR FINE-TUNING LIGHT EMISSION UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. 2023-11-30 US disclosed
US-11679372-B2 Multivariate metal-organic frameworks for fine-tuning light emission UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2023-06-20 US disclosed
US-11679372-B2 Multivariate metal-organic frameworks for fine-tuning light emission UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2023-06-20 US disclosed
US-11679372-B2 Multivariate metal-organic frameworks for fine-tuning light emission UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2023-06-20 US disclosed
EP-3625228-B1 PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2021-07-07 EP disclosed
US-20210113559-A1 PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2021-04-22 US disclosed
US-20070219179-A1 Indole Derivative Having Piperidine Ring EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-09-20 US disclosed
US-RE39590-E1 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them ISK AMERICAS INCORPORATED (US) 2007-04-24 US disclosed
EP-1757599-A1 INDOLE DERIVATIVES HAVING PIPERIDINE RINGS Eisai R&D Management Co., Ltd. (JP) 2007-02-28 EP disclosed
EP-1358156-B1 BENZ(G) INDOLES AND THEIR USE AS SPLA2 INHIBITORS LILLY CO ELI (US) 2007-02-21 EP disclosed
EP-1358156-B1 BENZ(G) INDOLES AND THEIR USE AS SPLA2 INHIBITORS LILLY CO ELI (US) 2007-02-21 EP disclosed
US-20050256103-A1 Indole derivative having piperidine ring EISAI CO., LTD. 2005-11-17 US disclosed
US-6916840-B2 Spla2 inhibitors ELI LILLY AND COMPANY (US) 2005-07-12 US disclosed
US-20040063967-A1 Novel spla2 inhibitors BEIGHT DOUGLAS WADE (US) 2004-04-01 US disclosed
EP-1358156-A2 BENZ(G) INDOLES AND THEIR USE AS SPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 2003-11-05 EP disclosed
WO-2002057231-A2 BENZ(G) INDOLES AND THEIR USE AS SPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11679372-B2 Multivariate metal-organic frameworks for fine-tuning light emission ILF2, MORF4L1, YTHDF2 ALDH1A1 3245/4885KDM4E 1226/4885TSHR 3555/4885
US-20070219179-A1 Indole Derivative Having Piperidine Ring HTR5A, HTR2C, HTR1A ALDH1A1 310/4885KDM4E 1505/4885TSHR 365/4885
US-11839613-B2 Pyrimidine derivatives as PGE2 receptor modulators PTGER1, PTGER4, PTGER2 ALDH1A1 468/4885KDM4E 1571/4885TSHR 654/4885
US-20230381740-A1 MULTIVARIATE METAL-ORGANIC FRAMEWORKS FOR FINE-TUNING LIGHT EMISSION ILF2, MORF4L1, YTHDF2 ALDH1A1 3245/4885KDM4E 1226/4885TSHR 3555/4885
US-20210113559-A1 PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS PTGER1, PTGER4, PTGER2 ALDH1A1 468/4885KDM4E 1571/4885TSHR 654/4885
US-12251679-B2 Multivariate metal-organic frameworks for fine-tuning light emission ILF2, MORF4L1, YTHDF2 ALDH1A1 3245/4885KDM4E 1226/4885TSHR 3555/4885
US-20040063967-A1 Novel spla2 inhibitors PLA2G12A, SPINT2, PLA2G4A ALDH1A1 2761/4885KDM4E 4327/4885TSHR 4674/4885
US-20050256103-A1 Indole derivative having piperidine ring HTR5A, HTR2C, HTR1A ALDH1A1 295/4885KDM4E 1558/4885TSHR 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.